What is UgenTec?
UgenTec, rebranded as Velsera, is a specialized provider of automation solutions for molecular laboratories. The company's FastFinder platform is designed to streamline sample flow, implement real-time quality control, and deliver actionable operational insights. Catering to clinical diagnostics, veterinary diagnostics, and pharmaceutical applications, Velsera serves a diverse clientele including labs, assay providers, and instrument partners. Their core mission is to enhance laboratory efficiency and diagnostic accuracy through reliable, integrated software solutions that optimize workflows, reduce operational costs, and ensure consistent, reproducible results in lab environments.
How much funding has UgenTec raised?
UgenTec has raised a total of $13M across 3 funding rounds:
Private Equity
$1.4M
Angel/Seed
$2.3M
Series A
$9.3M
Private Equity (2015): $1.4M, investors not publicly disclosed
Angel/Seed (2016): $2.3M led by BNP Paribas Fortis
Series A (2018): $9.3M supported by Herman Verrelst, Gemma Frisius Fund, Annie Vereecken, Lrm, KU Leuven, and IMEC
Key Investors in UgenTec
Gemma Frisius Fund
Gemma Frisius Fund, associated with KU Leuven, is an investment arm of one of Europe's oldest and most renowned universities, likely focusing on supporting innovative ventures emerging from academic research and development.
Lrm
LRM is a venture capital provider dedicated to fostering economic development and innovation within Limburg, offering strategic financial backing and managing business campuses to support sustainable growth.
BNP Paribas Fortis
BNP Paribas Fortis is a prominent Belgian banking institution providing a comprehensive range of financial services and solutions, likely supporting early-stage and growth-stage companies.
What's next for UgenTec?
With a substantial enterprise-level funding context and a recent strategic investment, Velsera is poised for significant scaling and innovation. The company's focus on automation and operational insights within molecular diagnostics positions it to capitalize on the growing demand for efficient and reliable laboratory solutions. Future developments are likely to involve further enhancement of the FastFinder platform, expanding its capabilities to address emerging challenges in diagnostics and research. Strategic partnerships and market penetration will be key as Velsera aims to solidify its leadership in the sector.
See full UgenTec company page
